CHORI Staff Directory
CHORI Intranet



























































The Big Picture
Active Clinical Studies at Children's Hospital & Research Center at Oakland

By Principal Investigator:
Principal Investigator Title IRB#:
Vichinsky, Elliott MD Cellular Mechanisms for Iron Storage in B Thalassemia and Sickle Cell Disease and Correlation with Oxidative Injury 2000-026
Vichinsky, Elliott MD Thalasemmia Clinical Research Network Registry 2001-023
Vichinsky, Elliott MD A Pilot Study of the Response of Oxidant Stress Induced Injury and Mitochondrial Dysfunction Biomarkers to Treatment with Iron Chelators: Ancillary Study of the Novartis ICL670 107 Open Label Phase III Trial 2003-011
Vichinsky, Elliott MD Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults with Sickle Cell Disease 2004-081
Vichinsky, Elliott MD The Collaborative Data Project 2006-007
Vichinsky, Elliott MD A Longitudinal Cohort Study of Patients with Thalassemia in the Thalassemia Clinical Research Network 2006-073
Vichinsky, Elliott MD A 5 Year Observational Study (registry) of Children Aged 2 to <6 Years at Enrollemnt with Hemosiderosis Treated with Deferasirox 2007-017
Vichinsky, Elliott MD Safety of Deferasirox (ICL670) and Deferocamine (Desferal or DFO) Combined Chelation Therapy in Patients with Transfusion Dependent Thalassemia and Ironoverload 2007-040
Vichinsky, Elliott MD A Phase IIA study of subcutaneous 5-AZA-2’-deoxycytidine (Decitabine) in patients with Thalassemia Intermedia 2008-048
Vichinsky, Elliott MD Modulation of Iron Deposition in Sickle Cell Disease and Other Hemoglobinopathies (Survey Study) 2010-019
Vichinsky, Elliott MD A 5-year, Prospective, Non-Interventional Multicenter Registry in Sickle Cell Disease Patients (Novartis US38) 2010-034
Vichinsky, Elliott MD 2010-055
Vichinsky, Elliott MD A Phase III, Prospective, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter Study of L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0-Thalassemia 2010-072
Vichinsky, Elliott MD Randomized, Double-Blind, Placebo-Controlled Trial of Deferiprone in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) 2012-059
Vichinsky, Elliott MD Prevention of Stroke after STOP, a Retrospective Chart Review (Post-STOP) 2012-065
Vichinsky, Elliott MD In Vitro Repair of the HbS Gene in CD34+ Cells 2012-088
Vichinsky, Elliott MD Hemoglobin S Polymerization and Modification Screening 2013-006
Viteri, Fernando MD, PhD Determination of Folate Levels in Density Fractionated Human Erythrocytes & In Vitro Kinetics of Folate Uptake / Efflux by Purified Red Blood Cells 2007-035
Wachtel, Renee MD Rett Syndrome Natural History 2005-085
Wachtel, Renee MD 2010-063
Walters, Mark MD Allogeneic Marrow Transplantation from HLA-Identical Related Donors for Treatment of Homozygous Thalassemia Major and other Red Cell Disease (Excluding Sickle Cell Anemia) Activation Date 6/23/93 2000-005
Walters, Mark MD International Bone Marrow Registry/Autologous Blood & Marrow Transplant Registry (IBMTR/ABMTR) 2002-077
Walters, Mark MD Hematopoietic Cell Transplantation for Treatment of Patients with Primary immunodeficiencies and other Nonmalignant Inherited Disorders using low-dose TBI and Fludarabine with or Without Campath®.  (2007-FH) 2007-011
Walters, Mark MD Multi-Center, Open Label, Randomized Trial Comparing Single versus Double Umbilical Cord Blood Transplantation in Pediatric patients with High Risk Leukemia or Myelodysplasia. (BMT-CTN-0501) 2007-072
Walters, Mark MD Unrelated Donor Hematopoietic Cell Transplantation for Children with Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen-(BMTCTN 0601) 2008-038
Walters, Mark MD Collection of Bone Marrow and Blood from Patients with Genetic Diseases of Blood Cells 2009-082
Walters, Mark MD A Pilot Trial of Unrelated Donor Hematopoietic Cell Transplantation for Children with Severe Thalassemia Using a Reduced Intensity Conditioning Regimen (The URTH Trial) 2010-006
Walters, Mark MD Nonmyeloablative Hematopoietic Cell Transplantation for Patients with Fanconi Anemia Using Alternative Marrow Donors: A Phase I/II Dose-Finding Study (Protocol 2064.00) 2011-010
Walters, Mark MD A Phase I/II Study of Hematopoietic Stem Cell Therapy for Young Adults with Severe Sickle Cell Disease 2011-043
Walters, Mark MD A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation (ACCL1031) 2011-059
Walters, Mark MD A Multicenter Access And Distribution Protocol For Unlicensed Cryopreserved Cord Blood Units (Cbus) For Transplantation In Pediatric And Adult Patients With Hematologic Malignancies And Other Indications 2011-060
Walters, Mark MD Moyamoya Syndrome Treated With Encephaloduroarteriosynangiosis Followed by Hematopoietic Cell Transplantation in Patients with Sickle Cell Disease 2011-086
Walters, Mark MD Familial Haploidentical T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (IND 14359) (NYMC-526) 2012-016
Walters, Mark MD A Dose Escalation of Clofarabine in Combination with Cytarabine and Total Body Irradiation Followed by Allogeneic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia and Non-Lymphoblastic Leukemia (CHNY-06-531) 2012-032
Walters, Mark MD A Phase 1/2, Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects with β-Thalassemia Major by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo with a Lentiviral βA-T87Q-Globin Vector (LentiGlobin® BB305 Drug Pro 2013-018
Walters, Patrick, Phd Dysregulation of the Innate Immune Response in thalassemia major: a Possible Mechanism for Increased Infection Risk 2008-074
Waterson, John MD PhD MPS I Registry Protocol and Patient Information and Authorization for Release of Clinical Information to the MPS I Registry 2004-096
Willinsky, John Mark, PhD The NIH Public Access Policy: Establishing a Basis for Assessing a Science Policy 2010-050
Zlotnick, Cheryl RN DrPH Health Status and Behaviors of Adults with Histories of Foster Care 2005-040
Zlotnick, Cheryl RN DrPH Alameda County Healthcare for Homeless Families Assessment 2008-081

Revised: Monday, May 13, 2013 1:40 PM

© 2005 Children's Hospital Oakland Research Institute
5700 Martin Luther King Jr Way • Oakland, California 94609
Phone 510-450-7600 • Fax 510-450-7910
Site MapDisclaimer